Showing results (41-50 of 48) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Journal of Hematology & Oncology|May 3, 2023
Antibody response to SARS-CoV-2 WT and Omicron BA.4/5 of inactivated COVID-19 vaccine in patients with lung cancer after second and booster immunizationChen Chen, Liyuan Dai, Cuiling Zheng, et al.Lung Cancer (Amsterdam, Netherlands)|February 15, 2024
Longitudinal plasma proteomic profiling of EML4-ALK positive lung cancer receiving ALK-TKIs therapyShasha Wang, Xuezhi Hao, Liyuan Dai, et al.Cancer Immunology, Immunotherapy : CII|May 24, 2025
Clinical, immune cell, and genetic features predicting survival and long-term response to first-line chemo-immunotherapy treatment for non-small cell lung cancerLiling Huang, Haohua Zhu, Liyuan Dai, et al.Genomics, Proteomics & Bioinformatics|December 11, 2024
A Novel IgG-IgM Autoantibody Panel Enhances Detection of Early-stage Lung Adenocarcinoma from Benign NodulesRongrong Luo, Xiying Li, Ruyun Gao, et al.Molecular & Cellular Proteomics : MCP|March 21, 2024
High-Throughput Antigen Microarray Identifies Longitudinal Prognostic Autoantibody for Chemoimmunotherapy in Advanced Non-Small Cell Lung CancerLiyuan Dai, Qiaoyun Tan, Lin Li, et al.Journal of the American Chemical Society|April 22, 2026
Nanofluid-Assisted Synthesis of High-Entropy Alloy NanoparticlesDi Yin, Liqiang Wang, You Meng, et al.Cancer|December 22, 2023
Identification of novel prognostic autoantibodies in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone via a high-throughput antigen microarrayLiyuan Dai, Haizhu Chen, Qiaoyun Tan, et al.Cancer Immunology, Immunotherapy : CII|November 24, 2021
Anti-PD1/PDL1 IgG subclass distribution in ten cancer types and anti-PD1 IgG4 as biomarker for the long time survival in NSCLC with anti-PD1 therapyQiaoyun Tan, Liyuan Dai, Yanrong Wang, et al.Pageof 5